Literature DB >> 11845882

Beta-receptor downregulation in congenital heart disease: a risk factor for complications after surgical repair?

Reiner Buchhorn1, Martin Hulpke-Wette, Wolfgang Ruschewski, Reinhard Pregla, Jens Fielitz, Roland Hetzer, Vera Regitz-Zagrosek.   

Abstract

BACKGROUND: Neurohormonal activation in children with heart failure due to congenital heart disease leads to downregulation of myocardial beta-receptors that may influence the postoperative course after cardiothoracic surgery.
METHODS: Myocardial biopsies of 26 children (aged 14+/-4 months) were obtained from the right atrium during cardiac surgery. Patients were allocated to either of two groups based on the duration of their intensive care unit stay: group 1 comprised those who stayed less than 7 days (n = 17), whereas group 2 comprised those who stayed more than 7 days, plus 3 infants who died during the early postoperative course (n = 9). For beta1- and beta2-mRNA quantitation, real-time polymerase chain reaction with fluorescence-labeled products was used.
RESULTS: Values for myocardial beta1-receptor gene expression were twice as high in group 1 children compared with group 2 (beta1-receptor 0.12+/-0.07 versus 0.06+/-0.03, p = 0.0016; beta2-receptor 0.12+/-0.07 versus 0.06+/-0.03, p = 0.0071). Beta-receptor gene expression in 16 children who received standard treatment for heart failure averaged lower than in the 10 children who received additional propranolol.
CONCLUSIONS: Beta-receptor downregulation due to congestive heart failure has an impact on the postoperative course in children with congenital disease and depends on heart failure therapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11845882     DOI: 10.1016/s0003-4975(01)03418-x

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  2 in total

1.  Incidence of adverse events requiring intervention after initiation of oral beta-blocker in pediatric cardiac intensive care patients.

Authors:  Jolie Britt; Brady S Moffett; Ronald A Bronicki; Paul A Checchia
Journal:  Pediatr Cardiol       Date:  2014-04-10       Impact factor: 1.655

2.  Role of β-blocker therapy in pediatric heart failure.

Authors:  Akash R Patel; Robert E Shaddy
Journal:  Ped Health       Date:  2010
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.